Two Sigma Investments
CBMG

Two Sigma Investments’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Two Sigma Investments’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,999
Closed -$440K – 3930
2020
Q3 		$440K Buy
23,999
+8,148
+51% +$137K ﹤0.01% 2341
2020
Q2 		$237K Buy
+15,851
New +$226K ﹤0.01% 2527
2020
Q1 		– Sell
-20,974
Closed -$341K – 4079
2019
Q4 		$341K Buy
+20,974
New +$350K ﹤0.01% 3093

Other funds holding CBMG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments's CBMG Position: Q4 2020 in Review

Two Sigma Investments sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q4 2020, closing a stake of 23,999 shares — an estimated $440K sold.

Two Sigma Investments first reported a position in CBMG in Q4 2019 and held it in 3 quarters. The position peaked at $440K in Q3 2020. 67 funds tracked by Wall St. Rank hold CBMG as of Q4 2020.

  • Two Sigma Investments reported no remaining Cellular Biomedicine Group, Inc. position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Investments sold 23,999 Cellular Biomedicine Group, Inc. shares in Q4 2020, an estimated $440K.
  • Two Sigma Investments first reported a position in Cellular Biomedicine Group, Inc. in Q4 2019 and held it in 3 quarters.
  • Two Sigma Investments's Cellular Biomedicine Group, Inc. position peaked at $440K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q4 2020.

Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.